Drug-eluting stent (DES) technology is the current state of the art in propping open, and keeping open, coronary and peripheral vessels. But DES doesn’t equal the “Holy Grail” in treating restenosis. That goal most likely will be achieved with a stent device that, after placement, disappears from the vasculature, leaving in place no material that is foreign to the body.